Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 7452858 Treatment of gestational diabetes

Patent 7452858 was granted and assigned to Amylin Pharmaceuticals on November, 2008 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 1 Feb, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 1 Feb, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11884713 Acylated glucagon analogues
0
Edits on 15 Sep, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 15 Sep, 2023
Edits made to:
Article (+240 characters)
Article

Patent abstract

Methods for treating gestational diabetes which comprise administration of an effective amount of an exendin or an exendin agonist, alone or in conjunction with other compounds or compositions that lower blood glucose levels.

Edits on 22 Jul, 2023
"Remove website redirecting to Patent Public Search front page"
Golden AI profile picture
Golden AI
edited on 22 Jul, 2023
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=0745285800
Edits on 24 May, 2023
"Remove leading 0 from patent number"
Golden AI profile picture
Golden AI
edited on 24 May, 2023
Edits made to:
Infobox (+1/-1 properties)
‌

US Patent 07452858 Treatment of gestational diabetes US Patent 7452858 Treatment of gestational diabetes

Infobox
Patent Number
0745285800
Patent Number
745285800
Edits on 22 Mar, 2023
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 22 Mar, 2023
Infobox
Is a
Patent
Patent
0
Current Assignee
Amylin Pharmaceuticals
Amylin Pharmaceuticals
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
074528580
Date of Patent
November 18, 2008
0
Patent Application Number
112820850
Date Filed
November 17, 2005
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=074528580
Patent Primary Examiner
‌
J. D. Schultz
0
Edits on 25 Sep, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 25 Sep, 2022
Infobox
Is a
Patent
Patent
0
Current Assignee
Amylin Pharmaceuticals
Amylin Pharmaceuticals
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
074528580
Date of Patent
November 18, 2008
0
Patent Application Number
112820850
Date Filed
November 17, 2005
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=074528580
Patent Primary Examiner
‌
J. D. Schultz
0
Edits on 14 Jun, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 14 Jun, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
https://pdfpiw.uspto.gov/.piw?Docid=07452858
Edits on 1 Dec, 2021
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 1 Dec, 2021
Edits made to:
Infobox (+8 properties)
‌

 US Patent 07452858 Treatment of gestational diabetes

Infobox
Is a
Patent
Patent
Current assignee
Amylin Pharmaceuticals
Amylin Pharmaceuticals
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
07452858
Date of patent
November 18, 2008
Patent application number
11282085
Date Filed
November 17, 2005
Patent primary examiner
‌
J. D. Schultz

Find more entities like US Patent 7452858 Treatment of gestational diabetes

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo